| Schedule of Dilutive Loss Per Share |
The following table summarizes the Company’s
potentially dilutive securities which have been excluded from the calculation of dilutive loss per share as their effect would be anti-dilutive:
| | |
Three Months Ended
April 30, | | |
Nine Months Ended
April 30, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Shares issuable upon exercise of stock options | |
| 1,676,670 | | |
| 1,033,409 | | |
| 1,676,670 | | |
| 1,033,409 | |
| Shares issuable upon vesting of restricted stock | |
| 418,398 | | |
| 578,578 | | |
| 418,398 | | |
| 578,578 | |
| Shares issuable upon exercise of warrants | |
| 645,191 | | |
| 1,087,100 | | |
| 645,191 | | |
| 1,087,100 | |
| | |
| 2,740,259 | | |
| 2,699,087 | | |
| 2,740,259 | | |
| 2,699,087 | |
|
| Schedule of Basic and Diluted Loss Per Share |
The following table summarizes the basic and diluted
loss per share calculations (in thousands, except for share and per share amounts):
| | |
Three Months Ended
April 30, | | |
Nine Months Ended
April 30, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Numerator: | |
| | |
| | |
| | |
| |
| Net loss | |
$ | (2,898 | ) | |
$ | (4,051 | ) | |
$ | (19,022 | ) | |
$ | (18,589 | ) |
| Net income (loss) attributable to noncontrolling interests | |
| 1,328 | | |
| 728 | | |
| 1,437 | | |
| (163 | ) |
| Net loss attributable to Rafael Holdings, Inc. | |
$ | (4,226 | ) | |
$ | (4,779 | ) | |
$ | (20,459 | ) | |
$ | (18,426 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Denominator: | |
| | | |
| | | |
| | | |
| | |
| Weighted average diluted shares | |
| 51,229,576 | | |
| 25,238,501 | | |
| 51,327,943 | | |
| 25,131,655 | |
| | |
| | | |
| | | |
| | | |
| | |
| Loss per share attributable to common stockholders | |
| | | |
| | | |
| | | |
| | |
| Basic and diluted | |
$ | (0.08 | ) | |
$ | (0.19 | ) | |
$ | (0.40 | ) | |
$ | (0.73 | ) |
|